propidium has been researched along with trichostatin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, KC; Han, SK; Jang, YS; Jeon, YM; Kim, BT; Kim, JG; Kim, SS; Kook, SH; Lee, HS; Lee, JC; Lee, KS; Lim, JY; Son, YO | 1 |
| Liu, S; Lu, D; Qu, X; Wang, P; Ying, H; Zhang, Y; Zhou, X; Zhu, H | 1 |
2 other study(ies) available for propidium and trichostatin a
| Article | Year |
|---|---|
Epstein-Barr virus-infected Akata cells are sensitive to histone deacetylase inhibitor TSA-provoked apoptosis.
Topics: Apoptosis; Caspase 8; Cell Cycle; Cell Line, Tumor; DNA; DNA Fragmentation; Enzyme Activation; Enzyme Inhibitors; Herpesvirus 4, Human; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; In Situ Nick-End Labeling; Jurkat Cells; Propidium | 2005 |
Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB.
Topics: Acetylation; Active Transport, Cell Nucleus; Blotting, Western; Chromatin Immunoprecipitation; DNA Primers; Drug Synergism; Flow Cytometry; Gene Expression Regulation, Viral; Green Fluorescent Proteins; HEK293 Cells; Histone Deacetylase Inhibitors; Histones; HIV Long Terminal Repeat; HIV-1; Humans; Hydroxamic Acids; Immunohistochemistry; Jurkat Cells; Microscopy, Fluorescence; NF-kappa B; Phorbol Esters; Propidium; Virus Latency; Vorinostat | 2012 |